eTheRNA immunotherapies Revenue and Competitors
Estimated Revenue & Valuation
- eTheRNA immunotherapies's estimated annual revenue is currently $19.1M per year.
- eTheRNA immunotherapies's estimated revenue per employee is $155,000
Employee Data
- eTheRNA immunotherapies has 123 Employees.
- eTheRNA immunotherapies grew their employee count by 3% last year.
eTheRNA immunotherapies's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | VP Product Development | Reveal Email/Phone |
3 | VP Human Resources | Reveal Email/Phone |
4 | Director, Business Development (CMO) | Reveal Email/Phone |
5 | Chief Business Officer | Reveal Email/Phone |
6 | QC Manager | Reveal Email/Phone |
7 | QA Engineer | Reveal Email/Phone |
8 | Equipment & Stock Management Coordinator | Reveal Email/Phone |
9 | Back-up aseptic production associate | Reveal Email/Phone |
10 | Principal Scientist Immuno-Oncology / Group leader immunomodulation Therapies | Reveal Email/Phone |
eTheRNA immunotherapies Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $2.8M | 18 | -33% | N/A | N/A |
#10 | $9.1M | 59 | -9% | N/A | N/A |
What Is eTheRNA immunotherapies?
eTheRNA is developing innovative immuno-oncology therapies based on its unique APC-activating messenger RNA platform.
keywords:N/AN/A
Total Funding
123
Number of Employees
$19.1M
Revenue (est)
3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
eTheRNA immunotherapies News
2022-04-19 - mRNA Vaccine Market Size, Scope And Forecast | Argos ...
Argos Therapeutics BioNTech AG, CureVac AG, eTheRNA Immunotherapies, Ethris GmbH, Incellart, Moderna Sangamo Therapeutics Tiba Biotech,...
2022-04-06 - eTheRNA Announces Relocation and Expansion of R&D Facility
GENT, Belgium, April 05, 2022 (GLOBE NEWSWIRE) -- eTheRNA immunotherapies NV (eTheRNA), an mRNA technology discovery and development...
2022-03-22 - eTheRNA Manufacturing Announces New LNP Formulation ...
This new LNP service uses eTheRNA's proprietary lipid libraries and ... eTheRNA immunotherapies NV, we can also provide support in stability...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $29M | 132 | 12% | N/A |
#2 | $48.3M | 144 | 12% | N/A |
#3 | $178.2M | 679 | 24% | N/A |
#4 | $307.9M | 1094 | -12% | N/A |